Concord Biotech Ltd
NSE:CONCORDBIO
Intrinsic Value
The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 077.75 INR. Compared to the current market price of 1 680.6 INR, Concord Biotech Ltd is Overvalued by 36%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Concord Biotech Ltd
Fundamental Analysis

Revenue & Expenses Breakdown
Concord Biotech Ltd
Balance Sheet Decomposition
Concord Biotech Ltd
Current Assets | 9.3B |
Cash & Short-Term Investments | 3.2B |
Receivables | 3.4B |
Other Current Assets | 2.7B |
Non-Current Assets | 8.3B |
Long-Term Investments | 95.5m |
PP&E | 8.1B |
Intangibles | 7.8m |
Other Non-Current Assets | 133.3m |
Free Cash Flow Analysis
Concord Biotech Ltd
INR | |
Free Cash Flow | INR |
Earnings Waterfall
Concord Biotech Ltd
Revenue
|
10.9B
INR
|
Cost of Revenue
|
-2.7B
INR
|
Gross Profit
|
8.2B
INR
|
Operating Expenses
|
-4.3B
INR
|
Operating Income
|
4B
INR
|
Other Expenses
|
-704.5m
INR
|
Net Income
|
3.3B
INR
|
CONCORDBIO Profitability Score
Profitability Due Diligence
Concord Biotech Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
Score
Concord Biotech Ltd's profitability score is 67/100. The higher the profitability score, the more profitable the company is.
CONCORDBIO Solvency Score
Solvency Due Diligence
Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Score
Concord Biotech Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
CONCORDBIO Price Targets Summary
Concord Biotech Ltd
According to Wall Street analysts, the average 1-year price target for CONCORDBIO is 1 914.29 INR with a low forecast of 1 636.2 INR and a high forecast of 2 296.35 INR.
Dividends
Current shareholder yield for CONCORDBIO is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one CONCORDBIO stock under the Base Case scenario is 1 077.75 INR.
Compared to the current market price of 1 680.6 INR, Concord Biotech Ltd is Overvalued by 36%.